PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer | The NEW ENGLAND JOURNAL Of MEDICINE

Authors: Andrea Cercek, M.D., Melissa Lumish, M.D. https://orcid.org/0000-0003-4173-5567, Jenna Sinopoli, N.P., Jill Weiss, B.A., Jinru Shia, M.D., MichelleLamendola-Essel, D.H.Sc., Imane H. El Dika, M.D., and Luis A. Diaz, Jr., M.D.

BACKGROUND

Neoadjuvant chemotherapy and radiation followed by surgical resection of the rectum is a standard treatment for locally advanced rectal cancer. A subset of rectal cancer is caused by a deficiency in mismatch repair. Because mismatch repair–deficient colorectal cancer is responsive to programmed death 1 (PD-1) blockade in the context of metastatic disease, it was hypothesized that checkpoint blockade could be effective in patients with mismatch repair–deficient, locally advanced rectal cancer.

METHODS

We initiated a prospective phase 2 study in which single-agent dostarlimab, an anti–PD-1 monoclonal antibody, was administered every 3 weeks for 6 months in patients with mismatch repair–deficient stage II or III rectal adenocarcinoma. This treatment was to be followed by standard chemoradiotherapy and surgery. Patients who had a clinical complete response after completion of dostarlimab therapy would proceed without chemoradiotherapy and surgery. The primary end points are sustained clinical complete response 12 months after completion of dostarlimab therapy or pathological complete response after completion of dostarlimab therapy with or without chemoradiotherapy and overall response to neoadjuvant dostarlimab therapy with or without chemoradiotherapy.
PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer

RESULTS

A total of 12 patients have completed treatment with dostarlimab and have undergone at least 6 months of follow-up. All 12 patients (100%; 95% confidence interval, 74 to 100) had a clinical complete response, with no evidence of tumor on magnetic resonance imaging, 18F-fluorodeoxyglucose–positron-emission tomography, endoscopic evaluation, digital rectal examination, or biopsy. At the time of this report, no patients had received chemoradiotherapy or undergone surgery, and no cases of progression or recurrence had been reported during follow-up (range, 6 to 25 months). No adverse events of grade 3 or higher have been reported.

CONCLUSIONS

Mismatch repair–deficient, locally advanced rectal cancer was highly sensitive to single-agent PD-1 blockade. Longer follow-up is needed to assess the duration of response. (Funded by the Simon and Eve Colin Foundation and others; ClinicalTrials.gov number, NCT04165772.)
Locally advanced rectal cancer is typically managed with multimodal therapy, including chemotherapy, radiation, and surgery. Current evidence supports a strategy involving the use of neoadjuvant therapy, in which induction chemotherapy with a fluoropyrimidine in combination with oxaliplatin is followed by chemoradiotherapy and then surgery.1-3 This approach results in a pathological complete response in up to a quarter of patients, but it is associated with marked complications and toxic effects — including bowel, urinary, and sexual dysfunction; infertility; and altered quality of life — in a substantial proportion of patients.4-6 In patients undergoing surgery, resection of the rectum is life-altering and often warrants a permanent diverting colostomy.6,7 Owing to the complications of surgery and the high frequency of pathological complete response, interest in organ-sparing nonoperative management is increasing. The use of clinical complete response that is achieved with neoadjuvant treatment as a surrogate for pathological complete response provides patients with a nonoperative option that results in a survival benefit that is similar to that in patients undergoing surgical resection.8-11
Approximately 5 to 10% of rectal adenocarcinomas are mismatch-repair deficient, and these tumors have been shown to respond poorly to standard chemotherapy regimens, including neoadjuvant chemotherapy in locally advanced rectal cancer.12-14 Immune checkpoint blockade alone has been shown to be highly effective as first-line treatment for patients with mismatch repair–deficient metastatic colorectal cancer, as well as for patients with treatment-refractory disease, with objective response rates of 33 to 55%, clinically significant durability of response, and prolonged overall survival.15-17
On the basis of the benefits seen in the context of metastatic disease, we hypothesized that single-agent programmed death 1 (PD-1) blockade alone might be beneficial in mismatch repair–deficient, locally advanced rectal cancer. To test this hypothesis, we initiated a phase 2 study to investigate the overall response and frequency of sustained clinical complete response to neoadjuvant treatment with dostarlimab, a PD-1 inhibitor, in this patient population.

Skip The Scoop | Seek Understanding

Looking Beyond the Female Firsts of Science History

Show Me

‘American Traitor’ Shows What Happens When the Bullies are in Charge

Show Me

From The Desk Of Donald J. Trump

Show Me

Daily Beast Boss Quashed ‘Sex Assault’ Allegations.

Show Me

BLM Co-Founder Patrisse Cullors to Step Down Following DCNF Reports of Potential Self-Dealing

Show Me

Israeli Bombs Killed 66 Kids in Gaza Including 12 Who Were Getting Help for Trauma from Past Attacks

Show Me

AP launches local news AI project with Knight Foundation

Show Me

Exclusive: Biden looks abroad for electric vehicle metals, in blow to U.S. miners

Show Me

Myanmar: Cease persecution of journalists

Show Me

The Real Curse To All Americans Is The Establishment Left & Right | Defund The Police Maxine Waters Even Used Federal Marshals To Protect Her | “Congress’s VIP Air Marshal Program Canceled after Maxine Waters Debacle”

Show Me

Bannon’s War Room | Saturday Edition Hour 2 | Recorded May 29, 2021 | Video: 48 Minutes 18 Seconds

Show Me

U.S. Announces Sanctions on Belarus Over Journalist’s Detention

Show Me

Punished in Hong Kong for Texting the Press

Show Me

Investigative Journalist and Author Sharri Markson Reveals How Dr. Fauci Restarted Gain of Function Research After Obama Administration Stopped it

Show Me

Rutgers leaders forced to apologize for statement condemning anti-Semitism

Show Me

ARIZONA: State Senator Wendy Rogers Reports From Maricopa Audit Floor, Says Results Could Be ‘Legally Actionable’

Show Me

No Mask Requirement at Summer Camps If Everyone Is Fully-Vaccinated: CDC

Show Me

Report Suggests Dr. Anthony Fauci Believed Experimenting on Contagious Viruses Worth the Risk of a Lab Accident

Show Me

Ex-mailman Admits to Dumping Mail, Ballots

Show Me

It’s Apparent What The Establishment, Big Tech & Mainstream Media Mean By A Perfect Election | “I challenge you (the poll worker) for filling in the Democrat straight ticket (for voters not present). Can I challenge that? (They reply) ‘No, it’s not a challenge. No document. Just push it through.’ That’s what they did” ~ Eyewitness Poll Observer | Video: 2 Minutes 47 Seconds

Show Me

CNN Pushes Bizarre Conspiracy Theory That Arizona’s Live Audit Cameras Are Controlled By One America News | “Ariz. Senate President Karen Fann stands her ground during CNN ambush interview” | Video: 3 Minutes 33 Seconds

Show Me

May 28, 2021 | Nightly News Rebroadcast | Video: 52 Minutes 08 Seconds

Show Me

“Paul Ryan is a gutless coward” ~ Steve Bannon | “Paul Ryan is a loser. . . a path to losing for the Republican party. . . a front man for the Uniparty.” ~ Matt Gaetz | Video 8 Minutes 41 Seconds

Show Me

Bannon’s War Room | Morning Edition Hour 1 | Recorded May 28, 2021 | Video: 48 Minutes 32 Seconds

Show Me

Bannon’s War Room | Morning Edition Hour 2 | Recorded May 28, 2021 | Video: 48 Minutes 50 Seconds

Show Me

Bannon’s War Room | Evening Edition | Recorded May 28, 2021 | Video: 48 Minutes 58 Seconds

Show Me

The Real Story – OAN Election Integrity with Sen. Doug Mastriano | Video: 8 Minutes 20 Seconds

Show Me

If You’re An American Who Witnessed Voter Fraud, You Will Get A Government Official Call and Let You Know, “I’m not scaring you. But, I am scaring you.” | United States Postal Service Whistleblower Being Coerced | Video: 2 Minutes 18 Seconds

Show Me

Black Lives Matter Founder Calls for “The End” of Israel.

Show Me

Former Astronaut Pleads Guilty in Crash That Killed 2 Young Girls

Show Me

NYT COVID reporter’s claim of lab-leak theory’s ‘racist roots’ hints at paper’s news priorities

Show Me

May 27, 2021 | Nightly News Rebroadcast | Video: 53 Minutes 11 Seconds

Show Me

Bannon’s War Room | Morning Edition Hour 1 | Recorded May 27, 2021 | Video: 48 Minutes 19 Seconds

Show Me

Bannon’s War Room | Morning Edition Hour 2 | Recorded May 27, 2021 | Video: 48 Minutes 30 Seconds

Show Me

Bannon’s War Room | Evening Edition | Recorded May 27, 2021 | Video: 48 Minutes 58 Seconds

Show Me

The Real Story – OAN America’s Audit Resumes with Ken Bennet

Show Me

May 26, 2021 | Nightly News Rebroadcast | Video: 53 Minutes 11 Seconds

Show Me

Bannon’s War Room | Morning Edition Hour 1 | Recorded May 26, 2021 | Video: 48 Minutes 28 Seconds

Show Me

Dr. Marty Makary on the U.S. Health Care System | Video: 1 Hour 21 Seconds

Show Me

Bannon’s War Room | Morning Edition Hour 2 | Recorded May 26, 2021 | Video: 48 Minutes 51 Seconds

Show Me